Last quarter (Q4 2023), Bicycle Therapeutics's total revenue was $5.33M, an increase of 67.38% from the same quarter last year. In Q4, Bicycle Therapeutics's net income was $-49.10M. See Bicycle Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 26.98M	$ 26.98M	$ 14.46M	$ 11.70M	$ 10.39M	$ 13.80M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 26.98M	$ 26.98M	$ 14.46M	$ 11.70M	-	-
Operating Expense	$ 216.92M	$ 216.92M	$ -131.12M	$ -77.31M	$ 62.35M	$ 40.10M
Operating Income	$ -189.95M	$ -189.95M	$ -116.65M	$ -65.62M	$ -51.96M	$ -26.30M
Net Non Operating Interest Income Expense	$ 10.74M	$ 10.74M	$ 2.41M	$ -2.86M	$ 226.00K	$ 814.00K
Other Income Expense	-	-	-	-	-	$ -5.38M
Pretax Income	$ -179.21M	$ -179.21M	$ -114.24M	$ -68.48M	$ -51.73M	$ -30.86M
Tax Provision	$ 1.50M	$ 1.50M	$ -1.50M	$ -1.70M	$ -724.00K	$ -254.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -180.71M	$ -180.70M	$ -112.74M	$ -66.78M	$ -51.01M	$ -30.61M
Basic EPS	$ -5.12	$ -5.08	$ -3.80	$ -2.67	$ -2.66	$ -2.77
Diluted EPS	$ -5.12	$ -5.08	$ -3.80	$ -2.67	$ -2.66	$ -2.77
Basic Average Shares	$ 142.37M	$ 35.59M	$ 29.66M	$ 25.06M	$ 19.15M	$ 11.05M
Diluted Average Shares	$ 142.37M	$ 35.59M	$ 29.66M	$ 25.06M	$ 19.15M	$ 11.05M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 216.92M	$ 216.92M	$ -131.12M	$ -77.31M	$ 62.35M	$ 40.10M
Net Income From Continuing And Discontinued Operation	$ -180.70M	$ -180.70M	$ -112.74M	$ -66.78M	$ -51.01M	$ -30.61M
Normalized Income	$ -119.78M	$ -141.57M	-	-	$ -51.01M	$ -30.61M
Interest Expense	-	-	-	-	$ 457.00K	$ 0.00
EBIT	$ -175.94M	$ -175.94M	$ -110.90M	$ -65.50M	$ -51.28M	$ -30.86M
EBITDA	$ -169.40M	$ -169.40M	$ -107.21M	$ -64.09M	$ -50.00M	$ -29.90M

Currency in USD

Bicycle Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing